Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00424437 · ClinicalTrials.gov registry record · Phase 3
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 320
- Enrollment target
NCT00424437 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 320 participants.
The verdict
NCT00424437, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 320 participants
- Enrollment target
Study Summary
To determine, in subjects with Type 1 Diabetes Mellitus: 1. Whether glycemic control can be achieved at least as effectively with an insulin regimen involving pre-meal inhaled insulin plus a single bedtime Ultralente injection as with a conventional subcutaneous insulin regimen involving 2-3 mixed Regular/NPH insulin injections per day. 2. The toleration and safety of inhaled insulin therapy and its effects after 6 months, if any, on measures of pulmonary function.
Interventions
- DRUG Inhaled human insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 1999-09 |
| Est. Completion | 2000-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00424437
The ClinicalTrials.gov registry entry for NCT00424437 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inhaled human insulin is the first listed.
NCT00424437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00424437 about?
NCT00424437 is a clinical study titled "Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.". To determine, in subjects with Type 1 Diabetes Mellitus: 1. Whether glycemic control can be achieved at least as effectively with an insulin regimen involving pre-meal inhaled insulin plus a single bedtime Ultralente injection as with a conventional subcutaneous insulin regimen involving 2-3 mixed ...
What is the current status of trial NCT00424437?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 320 participants. The study started on 1999-09. Estimated completion is 2000-09.
What interventions are being tested in trial NCT00424437?
The interventions under investigation include: Inhaled human insulin (DRUG).
Who is sponsoring clinical trial NCT00424437?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.